Features Screener Stocks Charts
Sign In Sign Up

Procter & Gamble Health Cash Flow Statement

NSE:PGHL | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

Cash Flow Insights

Cash Conversion

0.54x

PGHL's operating cash flow covered 54% of net income in FY 2025. Some earnings may be tied up in working capital.

Free Cash Flow

₹1.60B

PGHL's free cash flow was ₹1.60B in FY 2025, down 22.5% from FY 2024.

Dividend Coverage

0.7x

PGHL's free cash flow did not fully cover dividends in FY 2025. The company may be funding dividends from reserves or borrowings.

CapEx Intensity

5.1%

Capital expenditure was 5.1% of operating cash flow in FY 2025 for PGHL, indicating a capital-light business.

2-year PGHL cash flow snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Net Income 2.73B 3.12B
Cash flow Operating Activities 2.28B 1.69B
Investments in PPE -217.30M -85.60M
Cash flow Investing Activities -68.70M 95.90M
Dividend Paid -4.15B -2.32B
Cash flow Financing Activities -4.18B -2.35B
Cash at beginning of period 4.35B 2.39B
Cash at end of period 2.39B 1.82B
Free Cash Flow 2.07B 1.60B

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025